Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection

Published:2022-03 Issue: Volume:241 Page:83-95
ISSN:1931-5244
Container-title:Translational Research
language:en
Short-container-title:Translational Research

Author:

LATIF MUHAMMAD BILAL,SHUKLA SUDHANSHU,DEL RIO ESTRADA PERLA MARIANA,RIBEIRO SUSAN PEREIRA,SEKALY RAFICK PIERRE,SHARMA ASHISH ARUNKUMAR

Funder

National Cancer Institute

National Institutes of Health

Publisher

Elsevier BV

Subject

Biochemistry (medical),Public Health, Environmental and Occupational Health,General Medicine,Physiology (medical)

Reference148 articles.

1. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study;Garassino;Lancet Oncol,2020

2. Effect of Cancer on Clinical Outcomes of Patients With COVID-19: A Meta-Analysis of Patient Data;Giannakoulis;JCO Glob Oncol,2020

3. COVID-19 and Cancer: Current Challenges and Perspectives;Bakouny;Cancer Cell,2020

4. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China;Liang;Lancet Oncol,2020

5. COVID-19 in cancer patients: risk, clinical features, and management;Liu;Cancer Biol Med,2020

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered ACE2 and interferon landscape in the COVID-19 microenvironment correlate with the anti-PD-1 response in solid tumors;2024-07-23

2. Association of immune checkpoint inhibitors with SARS-CoV-2 infection rate and prognosis in patients with solid tumors: a systematic review and meta-analysis;Frontiers in Immunology;2024-06-03

3. COVID‐19 and cancer: Dichotomy of the menacing dilemma;MedComm – Oncology;2023-11-30

4. IL-6 as a predictor of survival rate in liver metastatic breast cancer patients with Covid-19 infection: A case series;International Journal of Surgery Case Reports;2023-06

5. The analysis of cathepsin L that mediates cellular SARS‐CoV‐2 infection leading to COVID‐19 in head and neck squamous cell carcinoma;Frontiers in Immunology;2023-05-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3